MedTrace Logo

Biomarkers of Chronic Obstructive Pulmonary Disease

NCT04963023 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2023-08-23

No results posted yet for this study

Summary

There are few studies about immunological explorations in COPD. Because of the complications of lung biopsies, analyses are generally made on blood samples instead of lung tissue. No study tried to classify COPD vs Asthma vs ACOS. The investigators wondered if there were differences in biomarkers between these groups. The investigators decided to open a pilot-study among COPD patients followed in Amiens-University Hospital. Each patient will be examined and a blood-test will be performed.

Conditions

Interventions

OTHER

Physical examinations

BPCO physical examinations

DIAGNOSTIC_TEST

blood test

blood test in order to study immunologic markers

Sponsors & Collaborators

  • Centre Hospitalier Universitaire, Amiens

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-15
Primary Completion
2023-07-01
Completion
2023-07-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04963023 on ClinicalTrials.gov